Relationship between the plasma concentration of C-reactive protein and severity of peripheral arterial disease

Clinical Medicine: Cardiology

Volumn 2009, Issue 3, 2009, Pages 1-7

  De Haro, Joaquin ^a,b   Acin, Francisco ^a   Medina, Francisco Jose ^a   Lopez Quintana, Alfonso ^a   March, Jose Ramon ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^b NONE   (Spain)

Author keywords

C reactive protein; Inflammatory origen; Peripheral arterial disease

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTERY DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; HEALTH CARE UTILIZATION; HUMAN; LEG REVASCULARIZATION; MAJOR CLINICAL STUDY; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

EID: 62849128371     PISSN: None     EISSN: 11781165     Source Type: Journal    
DOI: 10.4137/cmc.s1062     Document Type: Article

References (24)

1. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin and risks of cardiovascular disease in apparently healthy men. N Engl. J. Med. 1997;336:973-9.
2. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 1994;331:417-24.
3. Tracy RP, Lemaitre RN, Psaty BM, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol. 1997;17:1121-7.
4. Kuller LH, Tracy RP, Shaten J, Meilahn EN. for the MRFIT Research Group. Relationship of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Ann J Epidemiol. 1996;144:537-47.
5. Ridker PM, Hennekens CH, Buring JE, et al. C-Reactive Protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836-43.
6. Libby P, Ridker PM. Inflammation and Atherosclerosis: Role of C- Reactive Protein in risk assessment. Am J Med. 2004; 116(6A):9S-16S.
7. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998;97:425-8.
8. Lohr S. Sampling: Design and Analysis. Spain: International Thomson, 2000.
9. Marcy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy adults: implications for reference interval and epidemiologic methods. Clin Chem. 1997;43:52-8.
10. Cermak J, Key NS, Bach RR, Balle J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood. 1993;82:513-20.
11. Wolbink GJ, Brouwer MC, Buysmann S, ten Berge IJM, Hack CE. C-reactive protein mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes. J Immunol. 1996;157:473-9.
12. Buchta R, Pontet M, Fiedkin M. Binding of C-reactive protein to human neutrophils. FEBS Lett. 1987;211:165-8.
13. Reynolds GD, Vance RP. C-reactive protein: immunohistochemical localization in normal and atherosclerotic human aortas. Arch Pathol Lab Med. 1987;111:265-9.
14. Zonki C, Beauchamp M, Baron C, Filep JG. Prevention of in vitro neutrophil adhesion to endothelial cells through shedding of L-selectine by C-reactive protein and peptides derived from C-reactive protein. J Clin Invest. 1997;100:522-9.
15. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 1997;350:430-6.
16. Goldhaber SZ, Manson JE, Stampfer MJ, et al. Low-dose aspirin and subsequent peripheral arterial surgery in Physicians Health Study. Lancet. 1992;340:143-5.
17. Clapp BR, Hirschfield GM, Storry C, et al. Inflammation and endothelial function. Direct vascular effects of human C-reactive protein on Nitric Oxide bioavailability. Circulation. 2005;111:1530-6.
18. Woo J, Lynn H, Wong SYS, et al. Correlates for a low ankle-brachial index in elderly Chinese. Atherosclerosis. 2005 Aug 17.
19. Beckman JA, Preis O, Ridker PM, Gerhard-Herman M. Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (Myocardial Infarction, Stroke, and Death) Am J Cardiol. 2005;96:1374-8.
20. Zimmerman MA, Selzman CH, Cothren C, et al. Diagnostic implications of C-reactive protein. Arch Surg. 2003;138:220-4.
21. Vainas T, Stassen FRM, de Graaf R, et al. C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events J Vasc Surg. 2005;42:243-51.
22. Barani J, Nilsson JA, Mattiasson I, Lindblad B, Gottsater A. Inflammatory mediators are associated with 1-year mortality in critical limb ischemia. J Vasc Surg. 2005;42:75-80.
23. Folsom AR, Pankow JS, Tracy RP, et al. Association of C-.reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol. 2001;88:112-7.
24. Cassar K, Bachoo P, Ford L, Greaves M, Brittenden J. Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease. Eur J Vasc Endovasc Surg. 2005;29:171-6.